It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2016.
2016 | New Delhi, Delhi, India | ActiveTriozone Pharmaceuticals Private Limited, a active private limited company, was established on 02 February 2016 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U85100DL2016PTC290483. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Jitendra Kumar (Director), Sanchita Kumari (Additional Director). Past directors included Arun Kumar. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at H. No. B-286/D, Ekta Vihar Jaitpur Extn. Badarpur, New Delhi, Delhi, 110044.
U85100DL2016PTC290483
290483
02 February 2016
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Triozone Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jitendra Kumar | Director | 02 Feb 2016 | Current |
| Sanchita Kumari | Additional Director | 23 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Triozone Pharmaceuticals Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 6.6% increase. The company also saw a substantial improvement in profitability, with a 27.56% increase in profit. The company's net worth moved up by a moderate rise of 1.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Triozone Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Triozone Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Triozone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triozone Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Triozone Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
Triozone Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Delhi. was recorded as a recent event.
Sanchita Kumari was appointed as a Additional Director was appointed as a Additional Director on 23 Aug 2018 & has been associated with this company since 7 years 3 months . was recorded as a recent event.
Progress on Jitendra Kumar was appointed as a Director was appointed as a Director on 02 Feb 2016 & has been associated with this company since 9 years 10 months . was documented.
The activity Triozone Pharmaceuticals Private Limited was registered on 02 Feb 2016 with Roc Delhi & aged 9 years 10 months as per MCA records. was completed.
The CIN of Triozone Pharmaceuticals Private Limited is U85100DL2016PTC290483.
Triozone Pharmaceuticals Private Limited is headquartered at H. No. B-286/D, Ekta Vihar Jaitpur Extn. Badarpur, New Delhi, Delhi, 110044.
Triozone Pharmaceuticals Private Limited was incorporated on 02 February 2016.
The current directors of Triozone Pharmaceuticals Private Limited are
The primary industry of Triozone Pharmaceuticals Private Limited is Trade.
Triozone Pharmaceuticals Private Limited is unlisted.
The authorized capital of Triozone Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Triozone Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX